[Sensory-motor attack of spinal origin during the acute terminal phase of multiple sclerosis].
D002220:Carbamazepine / Q000627:therapeutic use; D003337:Corpus Callosum / Q000473:pathology; D005260:Female; D005911:Gliosis; D006801:Humans; D008526:Medulla Oblongata / Q000473:pathology; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D009461:Neurologic Manifestations; D010468:Perceptual Disorders / Q000209:etiology; D011149:Pons / Q000473:pathology; D012677:Sensation; D012688:Septum Pellucidum / Q000473:pathology; D013035:Spasm / Q000209:etiology; D013116:Spinal Cord / Q000473:pathology; D013118:Spinal Cord Diseases / Q000209:etiology*
D002220:Carbamazepine
Crises sensitivo-motrices d'origine spinale au cours d'une sclérose en plaques à poussée aiguë terminale